Bristol's University Hospitals NHS Trust haematology and oncology departments manage CML and GIST patients from across the South West of England. For Bristol patients requiring private Imatinib supply — including international patients attending Bristol's private oncology services, or those between NHS prescriptions — Imatib 400mg delivers identical clinical outcomes to brand Glivec at dramatically reduced cost.
FAQ 1: What are the most common side effects of Imatib and how are they managed?Imatinib (Imatib) is generally well tolerated compared to traditional chemotherapy, but common side effects do occur. Nausea is the most frequent — managed by taking Imatib with food and a large glass of water and using antiemetics if needed. Fluid retention causing periorbital (around the eyes) and ankle oedema occurs in 50-60% of patients — managed with dietary sodium restriction, diuretics if severe, and dose reduction in extreme cases. Muscle cramps — particularly at night — affect many patients and respond to quinine, magnesium supplementation, or dose timing adjustments. Myelosuppression (low blood counts) requires regular monitoring and occasional dose interruptions. Skin rash occurs in 30-40% and is typically mild and manageable with antihistamines or topical steroids. Liver enzyme elevation occurs in about 5% and requires monitoring. Bristol haematologists discuss all these side effects with patients at initiation and at every follow-up appointment.
